United Therapeutics Corporation (UTHR) — Financial ratios
Profitability, liquidity, leverage, and valuation ratios for United Therapeutics Corporation, with annual and quarterly history.
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Valuation | ||||||
| P/E Ratio | 16.17x | 13.34x | 10.45x | 17.40x | 20.39x | 13.03x |
| P/B Ratio | 3.04x | 2.47x | 1.72x | 2.64x | 2.45x | 1.98x |
| P/S Ratio | 6.78x | 5.54x | 4.42x | 6.53x | 5.76x | 4.52x |
| Profitability | ||||||
| Gross Margin | 87.9% | 89.2% | 88.9% | 92.4% | 92.7% | 92.7% |
| Operating Margin | 47.7% | 47.9% | 50.9% | 50.6% | 33.0% | 40.0% |
| Net Margin | 41.9% | 41.5% | 42.3% | 37.6% | 28.2% | 34.7% |
| EBITDA Margin | 57.2% | 57.5% | 59.6% | 53.7% | 43.7% | 43.6% |
| Liquidity | ||||||
| Current Ratio | 6.60x | 5.25x | 4.41x | 9.85x | 7.61x | 6.70x |
| Quick Ratio | 6.28x | 5.03x | 4.28x | 9.55x | 7.30x | 6.44x |
| Leverage | ||||||
| Debt/Equity | 0.00x | 0.05x | 0.12x | 0.17x | 0.20x | 0.24x |
YoY = year-over-year change. Source: FMP..